MFS
SMMT icon

Mirabella Financial Services’s Summit Therapeutics SMMT Stock Holding History

Mirabella Financial Services’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-36,380
Closed -$125K – 472
2020
Q3 		$125K Buy
+36,380
New +$126K 0.02% 320

Other funds holding SMMT

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return

Mirabella Financial Services's SMMT Position: Q4 2020 in Review

Mirabella Financial Services sold out of Summit Therapeutics (SMMT) in Q4 2020, closing a stake of 36,380 shares — an estimated $125K sold.

Mirabella Financial Services first reported a position in SMMT in Q3 2020 and held it in 1 quarter. The position peaked at $125K in Q3 2020. 37 funds tracked by Wall St. Rank hold SMMT as of Q4 2020.

  • Mirabella Financial Services reported no remaining Summit Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Mirabella Financial Services sold 36,380 Summit Therapeutics shares in Q4 2020, an estimated $125K.
  • Mirabella Financial Services first reported a position in Summit Therapeutics in Q3 2020 and held it in 1 quarter.
  • Mirabella Financial Services's Summit Therapeutics position peaked at $125K in Q3 2020.
  • 37 funds tracked by Wall St. Rank held Summit Therapeutics as of Q4 2020.

Based on Mirabella Financial Services's 13F filing for Q4 2020, filed 16 Feb 2021.